EurekAlert! Cancer Research

Journal: Pediatrics Open Science
Funder: UC Davis Comprehensive Cancer Center, Tobacco Cessation Policy Research Center, Tobacco Cessation Policy Research Center

6-Oct-2025

Microplastics found to change gut microbiome in first human-sample study

Beyond
Reports and Proceedings

New research presented today at UEG Week 2025 shows that microplastics – plastic particles smaller than 5mm commonly found in the environment – can alter the human gut microbiome, with some changes resembling patterns linked to depression and colorectal cancer.

Meeting: UEG Week 2025

6-Oct-2025

Former Scripps Research assistant professor awarded 2025 Nobel Prize in Physiology or Medicine

Scripps Research Institute
Grant and Award Announcement

Shimon Sakaguchi is honored for his revolutionary discovery of regulatory T cells—revealing how “immune tolerance” impacts autoimmune diseases, cancer and more.

6-Oct-2025

Tailoring & teamwork help hospitals reduce wasteful pre-surgery testing

Michigan Medicine - University of Michigan
Peer-Reviewed Publication

A pilot study in three hospitals showed how to achieve success in reducing unnecessary blood tests, scans and other tests in low-risk patients having straightforward operations; now, the effort is expanding to more hospitals.

Journal: JAMA Network Open
Funder: Agency for Healthcare Research and Quality

6-Oct-2025

Journal of Thoracic Oncology study recommends new grading system for invasive squamous cell carcinoma of the lung

International Association for the Study of Lung Cancer
Peer-Reviewed Publication

Invasive lung squamous cell carcinoma (LUSC)

accounts for approximately one-quarter of all lung cancers, but therapeutic options for LUSC remain limited, primarily due to the absence of well-defined, targetable molecular alterations. Therefore, histopathologic features are increasingly being explored as tools to enhance prognostic accuracy and guide treatment decisions.

Journal: Journal of Thoracic Oncology

6-Oct-2025

New Alliance trial aims to improve outcomes in metastatic prostate cancer

Alliance for Clinical Trials in Oncology
Business Announcement

The Alliance for Clinical Trials in Oncology has launched the ASPIRE trial—a large-scale, Phase III clinical study investigating whether adding chemotherapy to current standard treatments can extend survival for men living with advanced prostate cancer.

Funder: NIH/National Cancer Institute

6-Oct-2025

AI and the Future of Cancer Research and Cancer Care to headline October 24 gathering of global oncology leaders at the National Press Club: NFCR Global Summit to feature top scientists, entrepreneurs, and cancer-care innovators

National Foundation for Cancer Research
Meeting Announcement

AI and the Future of Cancer Research and Cancer Care to Headline October 24 Gathering of Global Oncology Leaders at the National Press Club: NFCR Global Summit to Feature Top Scientists, Entrepreneurs, and Cancer-Care Innovators

Event spotlights “what’s next” in cancer breakthroughs, entrepreneurship, and patient care, culminating in honoring Dr. Tony Hunter with the 2025 Szent-Györgyi Prize for Progress in Cancer Research